Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03.

Patrick Y. Wen,Michael Castro,Drew Watson,Shweta Kapoor,Ashish Kumar Agrawal,Aftab Alam,Kunal Ghosh Roy,Swaminathan Rajagopalan,Kabya Basu,Deepak Anil Lala,Nirjhar Mundkur,Jim Christie,Anusha Pampana,Sayani Basu,Diwyanshu Sahu,Yugandhara Narvekar,Divya Singh,Prashant Nair,Manmeet Ahluwalia

Superior overall survival (OS) and disease-free survival (DFS) predictions for patients with glioblastoma multiforme (GBM) using Cellworks Singula: myCare-022-03.

2021

Patrick Y. Wen
Michael Castro
Drew Watson
Shweta Kapoor
Ashish Kumar Agrawal
Aftab Alam
Kunal Ghosh Roy
Swaminathan Rajagopalan
Kabya Basu
Deepak Anil Lala
Nirjhar Mundkur
Jim Christie
Anusha Pampana
Sayani Basu
Diwyanshu Sahu
Yugandhara Narvekar
Divya Singh
Prashant Nair
Manmeet Ahluwalia

2017Background: The Cellworks Singula Therapeutic Response Index (TRI) has been developed to assist clinicians and GBM patients in choosing between competing therapeutic options. In contrast to app...

Keywords:

disease free survival
Distributed File System
Glioblastoma
Oncology
Medicine
overall survival
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations